COLORECTAL CARCINOMA
Clinical trials for COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo fails to shrink tumors in liver cancer trial
Disease control TerminatedThis study tested a combination of two drugs, VB-111 and nivolumab, in 14 adults with colorectal cancer that had spread to the liver and had not responded to prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial was stopped early, an…
Matched conditions: COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Pfizer's new cancer drug trial halted early after testing in just 10 patients
Disease control TerminatedThis early-stage study tested a new drug called PF-07826390, given alone or with another drug (sasanlimab), in people with advanced solid tumors like lung, colon, kidney, and ovarian cancers. The goal was to check safety, find the right dose, and see if the drug shrinks tumors. O…
Matched conditions: COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
Pfizer cancer drug trial halted early after only 9 patients
Disease control TerminatedThis early-stage study tested a new experimental drug (PF-07820435) alone or with another drug (sasanlimab) in people with advanced solid tumors like lung, skin, and kidney cancers. The goal was to check safety and find the right dose. Only 9 people took part before the study was…
Matched conditions: COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC